Micar Innovation (Micar21) listed as a Emerging Players in study on 'Computer-Aided Drug Discovery Services Market, 2018-2030 - Roots Analysis
Roots Analysis study on 'Computer-Aided Drug Discovery Services Market, 2018-2030'. Given the increase in complexity of the drug discovery process, the overall R&D spending in the pharmaceutical / biotechnology sector has grown from around USD 128 billion in 2008 to USD 158 billion in 2017. As a result, the industry is currently under tremendous pressure not only to meet the expectations of a growing patient population, but also to identify ways to mitigate the risks associated with novel drug discovery programs to avoid failure. Over the years, various computational tools and services have emerged, enabling the selection, modelling, analysis and optimization of potential lead candidates. The predictive power of computer-aided drug discovery (CADD) has proven to be extremely advantageous, allowing researchers to bypass the random screening of billions of molecules across hundreds of biological targets. As a result, players offering novel in silico drug discovery services, such as CADD, have now become an integral part of the pharmaceutical industry.
MICAR INNOVATION is a drug discovery factory. The company has found a niche where it is able to create a large societal impact by improving the quality of life through new blockbuster drug molecules for a large class of diseases. It focuses on non-clinical Proof-of-Concepts (POCs) in preclinical R&D and Hit-to-Lead (H2L) achievements in areas such as neuroscience, oncology, cardio-vascularity, dermatology, rare diseases. MICAR21 is their drug discovery platform for small molecule drug candidates. The business model is based on licensing their intellectual property to commercial partners and on the creation new spin out companies.
About Roots Analysis: provide market research and consulting in the pharmaceutical industry. Focussed on providing an informed and impartial view on key issues facing the industry, our research is primarily driven by an in-depth analysis covering the following parameters: Technology evolution // Research and development // Existing market landscape // Future Commercial potential // Regulatory concerns // Regional growth drivers // Risks and opportunitiesLink to: Study on Computer-Aided Drug Discovery Services Market, 2018-2030 Roots Analysis